Page 193 -
P. 193

Pharma Business Models


               of the Future






               C) The Healthy Patient:                                                               D) Reinventing pharma:
               ›  What kind of Customer Relationship does effective   prevention becomes the main   ›  What does our Value Proposition look like in this
                preventive medicine require?                         revenue generator                new landscape?
               ›  Who are the main partners we should involve in                                    ›  What roles will Customer Segments play under our   SCENARIOS
                developing our business model for preventive medicine?                                new business model?
               ›  What does the shift toward preventive medicine                                    ›  Should we develop relevant activities, such as
                imply about the relationship between doctors and                                      bioinformatics and gene sequencing, in-house or   187
                                                                                                                                          187
                our salespeople?                                                                      through partnerships?
                                                                                                                                             DESIGN




                                  personalized medicine                                             personalized medicine becomes
                                     remains a fad                                                      a market mainstay







                                                                                                    B) My.medicine
               A) Business as Usual                                                                 ›  What kinds of relationships will we have to establish
               ›  How will our business model look in the future if                                   with patients?
                these two drivers don’t change?                                                     ›  Which Distribution Channels are most appropriate
                                                                                                      for personalized medicine?
                                                                  treatment remains the main        ›  Which resources and activities, such as bioinformatics
                                                                     revenune generator               and gene sequencing, do we need to develop?
















          !"#$%&'(%)*+(%,,---1:9                                                                                                      /012013---2488-67
   188   189   190   191   192   193   194   195   196   197   198